Novant Health expands local access to minimally invasive lung cancer biopsy technology

WILMINGTON, NC (WWAY) — Patients in southeastern North Carolina now have expanded access to a minimally invasive option for diagnosing lung cancer, as Novant Health introduces new robotic bronchoscopy technology at its local facilities.

Funded by the Novant Health New Hanover Regional Medical Center Foundation, the Ion robotic bronchoscopy system allows physicians to biopsy small or hard-to-reach lung nodules with greater precision. The technology uses thin, flexible catheters to navigate narrow airways, offering an alternative to more invasive procedures.

Health officials say the advancement could help speed up diagnosis and treatment for patients with suspected lung cancer. “Our expert physicians are now able to offer minimally invasive lung biopsies to promptly determine whether further treatment is needed,” said Dr. Heather Davis, chief clinical officer for Novant Health’s coastal region.

Lung nodules are often detected during imaging for other conditions. Traditionally, some patients undergo routine monitoring to track changes over time. The new technology gives patients the option to pursue earlier biopsy, even in areas that were previously difficult to access.

According to the American Lung Association, only 28% of lung cancers are diagnosed at an early stage, when survival rates are significantly higher.

Novant Health is also working to improve early detection through its incidental lung nodule program, which flags abnormalities found during unrelated scans and ensures patients receive appropriate follow-up care.

Health leaders say the addition of robotic bronchoscopy strengthens the region’s ability to diagnose lung cancer earlier and connect patients to timely treatment.